Association between serum uric acid levels and incidence of nonalcoholic fatty liver disease in users of preventive medicine service in southern Brazil: a retrospective study

Bulletin of the National Research Centre

Table 3 Results of the adjustment of multivariate models for steatosis progression considering variables of the first evaluation of patients

	Variables included in the model	p*	OR**	IC 95%***
Model 1	E1^# Uric acid	< 0.001	1.68	1.30–2.16
Model 2	E1^# Uric acid	0.008	1.46	1.10–1.93
Model 2	Sex	0.055	4.48	0.96–20.91
Model 3	E1^# Uric acid	0.410	1.16	0.81–1.65
	Sex	0.190	2.94	0.58–14.9
	E1^# AC^$	< 0.001	1.10	1.05–1.15
Model 4	E1^# Uric acid	0.479	1.14	0.79–1.65
	Sex	0.185	3.06	0.58–16.2
	E1^# AC^$	< 0.001	1.01	1.05–1.14
	E1^# Physical activity	0.137	0.55	0.25–1.21
Model 5	E1^# Uric acid	0.534	1.12	0.78–1.62
	Sex	0.243	2.72	0.50–14.8
	E1^# AC^$	< 0.001	1.09	1.04–1.14
	E1^# Physical activity	0.110	0.52	0.23–1.16
	E1^# Dyslipidemia	0.012	2.7	1.24–5.89
Model 6	E1^# Uric acid	0.181	1.38	0.85–2.23
	Sex	0.570	1.67	0.28–10.1
	E1^# AC^$	0.064	1.06	1.00–1.12
	E1^# Physical activity	0.118	0.45	0.16–1.24
	E1^# HbA1c^%	0.583	1.23	0.59–2.57
Model 7	E1^# Uric acid	0.269	1.32	0.80–2.16
	Sex	0.548	1.73	0.28–10.7
	E1^# AC^$	0.103	1.05	0.99–1.11
	E1^# Physical activity	0.066	0.37	0.13–1.08
	E1^# Dyslipidemia	0.050	2.84	0.98–8.17
	E1^# HbA1c^%	0.760	1.12	0.54–2.33

*Logistic regression model and Wald test, p < 0.05. **OR (odds ratio). ***IC95% (95% confidence intervals). ^#E1 (evaluation 1). ^$AC (abdominal circumference). ^%HbA1c (glycated hemoglobin)